Table of Content

1 Animal Biological Vaccine Market Overview
1.1 Product Overview and Scope of Animal Biological Vaccine
1.2 Animal Biological Vaccine Segment by Type
1.2.1 Global Animal Biological Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Animal Biological Vaccine Segment by Application
1.3.1 Global Animal Biological Vaccine Market Value by Application: (2024-2034)
1.3.2 Porcine
1.3.3 Poultry
1.3.4 Livestock
1.3.5 Companion Animals
1.3.6 Aquaculture
1.4 Global Animal Biological Vaccine Market Size Estimates and Forecasts
1.4.1 Global Animal Biological Vaccine Revenue 2018-2034
1.4.2 Global Animal Biological Vaccine Sales 2018-2034
1.4.3 Global Animal Biological Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Animal Biological Vaccine Market Competition by Manufacturers
2.1 Global Animal Biological Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Animal Biological Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Animal Biological Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Animal Biological Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Animal Biological Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Biological Vaccine, Product Type & Application
2.7 Animal Biological Vaccine Market Competitive Situation and Trends
2.7.1 Animal Biological Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Biological Vaccine Players Market Share by Revenue
2.7.3 Global Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Biological Vaccine Retrospective Market Scenario by Region
3.1 Global Animal Biological Vaccine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Animal Biological Vaccine Global Animal Biological Vaccine Sales by Region: 2018-2034
3.2.1 Global Animal Biological Vaccine Sales by Region: 2018-2024
3.2.2 Global Animal Biological Vaccine Sales by Region: 2024-2034
3.3 Global Animal Biological Vaccine Global Animal Biological Vaccine Revenue by Region: 2018-2034
3.3.1 Global Animal Biological Vaccine Revenue by Region: 2018-2024
3.3.2 Global Animal Biological Vaccine Revenue by Region: 2024-2034
3.4 North America Animal Biological Vaccine Market Facts & Figures by Country
3.4.1 North America Animal Biological Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Animal Biological Vaccine Sales by Country (2018-2034)
3.4.3 North America Animal Biological Vaccine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Biological Vaccine Market Facts & Figures by Country
3.5.1 Europe Animal Biological Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Animal Biological Vaccine Sales by Country (2018-2034)
3.5.3 Europe Animal Biological Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Biological Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Biological Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Animal Biological Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific Animal Biological Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Biological Vaccine Market Facts & Figures by Country
3.7.1 Latin America Animal Biological Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Animal Biological Vaccine Sales by Country (2018-2034)
3.7.3 Latin America Animal Biological Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Biological Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Biological Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Animal Biological Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Animal Biological Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Animal Biological Vaccine Sales by Type (2018-2034)
4.1.1 Global Animal Biological Vaccine Sales by Type (2018-2024)
4.1.2 Global Animal Biological Vaccine Sales by Type (2024-2034)
4.1.3 Global Animal Biological Vaccine Sales Market Share by Type (2018-2034)
4.2 Global Animal Biological Vaccine Revenue by Type (2018-2034)
4.2.1 Global Animal Biological Vaccine Revenue by Type (2018-2024)
4.2.2 Global Animal Biological Vaccine Revenue by Type (2024-2034)
4.2.3 Global Animal Biological Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Animal Biological Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Animal Biological Vaccine Sales by Application (2018-2034)
5.1.1 Global Animal Biological Vaccine Sales by Application (2018-2024)
5.1.2 Global Animal Biological Vaccine Sales by Application (2024-2034)
5.1.3 Global Animal Biological Vaccine Sales Market Share by Application (2018-2034)
5.2 Global Animal Biological Vaccine Revenue by Application (2018-2034)
5.2.1 Global Animal Biological Vaccine Revenue by Application (2018-2024)
5.2.2 Global Animal Biological Vaccine Revenue by Application (2024-2034)
5.2.3 Global Animal Biological Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Animal Biological Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck Animal Biological Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Zoetis Animal Biological Vaccine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merial/Sanofi
6.3.1 Merial/Sanofi Corporation Information
6.3.2 Merial/Sanofi Description and Business Overview
6.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Merial/Sanofi Animal Biological Vaccine Product Portfolio
6.3.5 Merial/Sanofi Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Boehringer Ingelheim Animal Biological Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Ceva Animal Biological Vaccine Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Corporation Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 CAHIC Animal Biological Vaccine Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 HVRI Animal Biological Vaccine Product Portfolio
6.7.5 HVRI Recent Developments/Updates
6.8 Ringpu Biology
6.8.1 Ringpu Biology Corporation Information
6.8.2 Ringpu Biology Description and Business Overview
6.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Ringpu Biology Animal Biological Vaccine Product Portfolio
6.8.5 Ringpu Biology Recent Developments/Updates
6.9 Yebio
6.9.1 Yebio Corporation Information
6.9.2 Yebio Description and Business Overview
6.9.3 Yebio Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Yebio Animal Biological Vaccine Product Portfolio
6.9.5 Yebio Recent Developments/Updates
6.10 DHN
6.10.1 DHN Corporation Information
6.10.2 DHN Description and Business Overview
6.10.3 DHN Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 DHN Animal Biological Vaccine Product Portfolio
6.10.5 DHN Recent Developments/Updates
6.11 WINSUN
6.11.1 WINSUN Corporation Information
6.11.2 WINSUN Animal Biological Vaccine Description and Business Overview
6.11.3 WINSUN Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 WINSUN Animal Biological Vaccine Product Portfolio
6.11.5 WINSUN Recent Developments/Updates
6.12 Elanco/Eli Lilly
6.12.1 Elanco/Eli Lilly Corporation Information
6.12.2 Elanco/Eli Lilly Animal Biological Vaccine Description and Business Overview
6.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Elanco/Eli Lilly Animal Biological Vaccine Product Portfolio
6.12.5 Elanco/Eli Lilly Recent Developments/Updates
6.13 Virbac
6.13.1 Virbac Corporation Information
6.13.2 Virbac Animal Biological Vaccine Description and Business Overview
6.13.3 Virbac Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Virbac Animal Biological Vaccine Product Portfolio
6.13.5 Virbac Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Animal Biological Vaccine Description and Business Overview
6.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Jinyu Bio-Technology Animal Biological Vaccine Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 ChengDu Tecbond
6.15.1 ChengDu Tecbond Corporation Information
6.15.2 ChengDu Tecbond Animal Biological Vaccine Description and Business Overview
6.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 ChengDu Tecbond Animal Biological Vaccine Product Portfolio
6.15.5 ChengDu Tecbond Recent Developments/Updates
6.16 CAVAC
6.16.1 CAVAC Corporation Information
6.16.2 CAVAC Animal Biological Vaccine Description and Business Overview
6.16.3 CAVAC Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 CAVAC Animal Biological Vaccine Product Portfolio
6.16.5 CAVAC Recent Developments/Updates
6.17 Kyoto Biken
6.17.1 Kyoto Biken Corporation Information
6.17.2 Kyoto Biken Animal Biological Vaccine Description and Business Overview
6.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Kyoto Biken Animal Biological Vaccine Product Portfolio
6.17.5 Kyoto Biken Recent Developments/Updates
6.18 FATRO
6.18.1 FATRO Corporation Information
6.18.2 FATRO Animal Biological Vaccine Description and Business Overview
6.18.3 FATRO Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 FATRO Animal Biological Vaccine Product Portfolio
6.18.5 FATRO Recent Developments/Updates
6.19 Vaksindo
6.19.1 Vaksindo Corporation Information
6.19.2 Vaksindo Animal Biological Vaccine Description and Business Overview
6.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Vaksindo Animal Biological Vaccine Product Portfolio
6.19.5 Vaksindo Recent Developments/Updates
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Animal Biological Vaccine Description and Business Overview
6.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Bio-Labs Animal Biological Vaccine Product Portfolio
6.20.5 Bio-Labs Recent Developments/Updates
6.21 Avimex Animal
6.21.1 Avimex Animal Corporation Information
6.21.2 Avimex Animal Animal Biological Vaccine Description and Business Overview
6.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Avimex Animal Animal Biological Vaccine Product Portfolio
6.21.5 Avimex Animal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Biological Vaccine Industry Chain Analysis
7.2 Animal Biological Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Biological Vaccine Production Mode & Process
7.4 Animal Biological Vaccine Sales and Marketing
7.4.1 Animal Biological Vaccine Sales Channels
7.4.2 Animal Biological Vaccine Distributors
7.5 Animal Biological Vaccine Customers
8 Animal Biological Vaccine Market Dynamics
8.1 Animal Biological Vaccine Industry Trends
8.2 Animal Biological Vaccine Market Drivers
8.3 Animal Biological Vaccine Market Challenges
8.4 Animal Biological Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Biological Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Animal Biological Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Animal Biological Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Animal Biological Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Animal Biological Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Animal Biological Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Animal Biological Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Animal Biological Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Animal Biological Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Animal Biological Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Biological Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Animal Biological Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Biological Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biological Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Biological Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Animal Biological Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Animal Biological Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Animal Biological Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Animal Biological Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Animal Biological Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Animal Biological Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Animal Biological Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Animal Biological Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Animal Biological Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Animal Biological Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Animal Biological Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Animal Biological Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Animal Biological Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Animal Biological Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Animal Biological Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Animal Biological Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Animal Biological Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Animal Biological Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Animal Biological Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Animal Biological Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Animal Biological Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Animal Biological Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Animal Biological Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Animal Biological Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Animal Biological Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Animal Biological Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Animal Biological Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Animal Biological Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Animal Biological Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Animal Biological Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Animal Biological Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Animal Biological Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Animal Biological Vaccine Price (USD/Unit) by Type (2018-2024)
Table 59. Global Animal Biological Vaccine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Animal Biological Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Animal Biological Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Animal Biological Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Animal Biological Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Animal Biological Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Animal Biological Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Animal Biological Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Animal Biological Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Animal Biological Vaccine Price (USD/Unit) by Application (2018-2024)
Table 69. Global Animal Biological Vaccine Price (USD/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck Animal Biological Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Zoetis Animal Biological Vaccine Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Merial/Sanofi Corporation Information
Table 81. Merial/Sanofi Description and Business Overview
Table 82. Merial/Sanofi Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Merial/Sanofi Animal Biological Vaccine Product
Table 84. Merial/Sanofi Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Boehringer Ingelheim Animal Biological Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Ceva Corporation Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Ceva Animal Biological Vaccine Product
Table 94. Ceva Recent Developments/Updates
Table 95. CAHIC Corporation Information
Table 96. CAHIC Description and Business Overview
Table 97. CAHIC Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. CAHIC Animal Biological Vaccine Product
Table 99. CAHIC Recent Developments/Updates
Table 100. HVRI Corporation Information
Table 101. HVRI Description and Business Overview
Table 102. HVRI Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. HVRI Animal Biological Vaccine Product
Table 104. HVRI Recent Developments/Updates
Table 105. Ringpu Biology Corporation Information
Table 106. Ringpu Biology Description and Business Overview
Table 107. Ringpu Biology Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Ringpu Biology Animal Biological Vaccine Product
Table 109. Ringpu Biology Recent Developments/Updates
Table 110. Yebio Corporation Information
Table 111. Yebio Description and Business Overview
Table 112. Yebio Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Yebio Animal Biological Vaccine Product
Table 114. Yebio Recent Developments/Updates
Table 115. DHN Corporation Information
Table 116. DHN Description and Business Overview
Table 117. DHN Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. DHN Animal Biological Vaccine Product
Table 119. DHN Recent Developments/Updates
Table 120. WINSUN Corporation Information
Table 121. WINSUN Description and Business Overview
Table 122. WINSUN Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. WINSUN Animal Biological Vaccine Product
Table 124. WINSUN Recent Developments/Updates
Table 125. Elanco/Eli Lilly Corporation Information
Table 126. Elanco/Eli Lilly Description and Business Overview
Table 127. Elanco/Eli Lilly Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Elanco/Eli Lilly Animal Biological Vaccine Product
Table 129. Elanco/Eli Lilly Recent Developments/Updates
Table 130. Virbac Corporation Information
Table 131. Virbac Description and Business Overview
Table 132. Virbac Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Virbac Animal Biological Vaccine Product
Table 134. Virbac Recent Developments/Updates
Table 135. Jinyu Bio-Technology Corporation Information
Table 136. Jinyu Bio-Technology Description and Business Overview
Table 137. Jinyu Bio-Technology Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Jinyu Bio-Technology Animal Biological Vaccine Product
Table 139. Jinyu Bio-Technology Recent Developments/Updates
Table 140. ChengDu Tecbond Corporation Information
Table 141. ChengDu Tecbond Description and Business Overview
Table 142. ChengDu Tecbond Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. ChengDu Tecbond Animal Biological Vaccine Product
Table 144. ChengDu Tecbond Recent Developments/Updates
Table 145. CAVAC Corporation Information
Table 146. CAVAC Description and Business Overview
Table 147. CAVAC Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. CAVAC Animal Biological Vaccine Product
Table 149. CAVAC Recent Developments/Updates
Table 150. Kyoto Biken Corporation Information
Table 151. Kyoto Biken Description and Business Overview
Table 152. Kyoto Biken Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Kyoto Biken Animal Biological Vaccine Product
Table 154. Kyoto Biken Recent Developments/Updates
Table 155. FATRO Corporation Information
Table 156. FATRO Description and Business Overview
Table 157. FATRO Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. FATRO Animal Biological Vaccine Product
Table 159. FATRO Recent Developments/Updates
Table 160. Vaksindo Corporation Information
Table 161. Vaksindo Description and Business Overview
Table 162. Vaksindo Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Vaksindo Animal Biological Vaccine Product
Table 164. Vaksindo Recent Developments/Updates
Table 165. Bio-Labs Corporation Information
Table 166. Bio-Labs Description and Business Overview
Table 167. Bio-Labs Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. Bio-Labs Animal Biological Vaccine Product
Table 169. Bio-Labs Recent Developments/Updates
Table 170. Avimex Animal Corporation Information
Table 171. Avimex Animal Description and Business Overview
Table 172. Avimex Animal Animal Biological Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Avimex Animal Animal Biological Vaccine Product
Table 174. Avimex Animal Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Animal Biological Vaccine Distributors List
Table 178. Animal Biological Vaccine Customers List
Table 179. Animal Biological Vaccine Market Trends
Table 180. Animal Biological Vaccine Market Drivers
Table 181. Animal Biological Vaccine Market Challenges
Table 182. Animal Biological Vaccine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Biological Vaccine
Figure 2. Global Animal Biological Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Animal Biological Vaccine Market Share by Type in 2022 & 2034
Figure 4. Oral Product Picture
Figure 5. Subcutaneous Product Picture
Figure 6. Intramuscular Product Picture
Figure 7. Others Product Picture
Figure 8. Global Animal Biological Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Animal Biological Vaccine Market Share by Application in 2022 & 2034
Figure 10. Porcine
Figure 11. Poultry
Figure 12. Livestock
Figure 13. Companion Animals
Figure 14. Aquaculture
Figure 15. Global Animal Biological Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Animal Biological Vaccine Market Size (2018-2034) & (US$ Million)
Figure 17. Global Animal Biological Vaccine Sales (2018-2034) & (K Units)
Figure 18. Global Animal Biological Vaccine Average Price (USD/Unit) & (2018-2034)
Figure 19. Animal Biological Vaccine Report Years Considered
Figure 20. Animal Biological Vaccine Sales Share by Manufacturers in 2022
Figure 21. Global Animal Biological Vaccine Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Animal Biological Vaccine Players: Market Share by Revenue in 2022
Figure 23. Animal Biological Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Animal Biological Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 25. North America Animal Biological Vaccine Sales Market Share by Country (2018-2034)
Figure 26. North America Animal Biological Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. U.S. Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Canada Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Europe Animal Biological Vaccine Sales Market Share by Country (2018-2034)
Figure 30. Europe Animal Biological Vaccine Revenue Market Share by Country (2018-2034)
Figure 31. Germany Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. France Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. U.K. Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Italy Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Russia Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Asia Pacific Animal Biological Vaccine Sales Market Share by Region (2018-2034)
Figure 37. Asia Pacific Animal Biological Vaccine Revenue Market Share by Region (2018-2034)
Figure 38. China Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Japan Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. South Korea Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. India Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Australia Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Taiwan Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Indonesia Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Thailand Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Malaysia Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Philippines Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Animal Biological Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Latin America Animal Biological Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Animal Biological Vaccine Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa Animal Biological Vaccine Revenue Market Share by Country (2018-2034)
Figure 55. Turkey Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. U.A.E Animal Biological Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of Animal Biological Vaccine by Type (2018-2034)
Figure 59. Global Revenue Market Share of Animal Biological Vaccine by Type (2018-2034)
Figure 60. Global Animal Biological Vaccine Price (USD/Unit) by Type (2018-2034)
Figure 61. Global Sales Market Share of Animal Biological Vaccine by Application (2018-2034)
Figure 62. Global Revenue Market Share of Animal Biological Vaccine by Application (2018-2034)
Figure 63. Global Animal Biological Vaccine Price (USD/Unit) by Application (2018-2034)
Figure 64. Animal Biological Vaccine Value Chain
Figure 65. Animal Biological Vaccine Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed